Cardima Preparing For Pivotal AF Trials Of Revelation Ablation Catheter
This article was originally published in The Gray Sheet
Executive Summary
Cardima will begin a 60-100 patient, 10-center pivotal atrial fibrillation trial of its Revelation cardiac ablation microcatheter pending FDA approval of the company's feasibility trial, according to an Oct. 23 release.